MaC Venture Capital & Next Chymia’s seed investment into Afya Rekod’s operations in Africa for USD 2 million

Lead party: MaC Venture Capital (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Afya Rekod Limited (private company) · Sector: Healthcare, Health Care Administration · Countries of operation: Nigeria, Kenya, Cameroon, Uganda, Zambia, South Africa Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity ·…


Lead party: MaC Venture Capital (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Afya Rekod Limited (private company) · Sector: Healthcare, Health Care Administration · Countries of operation: Nigeria, Kenya, Cameroon, Uganda, Zambia, South Africa

Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Seed · Deal amount: US$2m · Fund: MaC Venture Capital Fund I

Lead investor/buyer: MaC Venture Capital · Investors/buyers: MaC Venture Capital, Next Chymia Consulting HK Limited

Legal advisers: not identified in the source record.

Source: announced 2 February 2022. Original announcement: techcabal.com.